5 More Manufactures Given License To Produce Black Fungus Treatment Drug: Government

Efforts are being made to supplement the domestic availability of the anti-fungal drug through import, the ministry said, adding that 3,63,000 vials of Amphotericin-B will be imported in May.

The Union Health Ministry on Friday said license has been given to five more manufactures for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July. Efforts are being made to supplement the domestic availability of the anti-fungal drug through import, the ministry said, adding that 3,63,000 vials of Amphotericin-B will be imported in May, resulting in the total availability of 5,26,752 vials (inclusive of the domestic production) in the country. It said 3,15,000 vials will be imported in June and along with the domestic supply, the countrywide availability of Amphotericin-B will be enhanced to 5,70,114 vials in June. Several states and union territories have reported an increasing number of patients suffering from COVID complications in the recent days in the form of Mucormycosis, popularly known as black fungus, the ministry said in a statement.